Medovex Corp Performance
| HCYTDelisted Stock | USD 2.21 0.00 0.00% |
The company secures a Beta (Market Risk) of 0.68, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Medovex Corp's returns are expected to increase less than the market. However, during the bear market, the loss of holding Medovex Corp is expected to be smaller as well. Medovex Corp right now secures a risk of 0.0%. Please verify Medovex Corp mean deviation, maximum drawdown, as well as the relationship between the Maximum Drawdown and day typical price , to decide if Medovex Corp will be following its current price movements.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Medovex Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Medovex Corp is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors. ...more
| Begin Period Cash Flow | 1.6 M | |
| Total Cashflows From Investing Activities | -7830.00 |
Medovex |
Medovex Corp Relative Risk vs. Return Landscape
If you would invest 221.00 in Medovex Corp on September 2, 2024 and sell it today you would earn a total of 0.00 from holding Medovex Corp or generate 0.0% return on investment over 90 days. Medovex Corp is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of otc stocks are less volatile than Medovex, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Medovex Corp Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Medovex Corp's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Medovex Corp, and traders can use it to determine the average amount a Medovex Corp's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| HCYT |
Based on monthly moving average Medovex Corp is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Medovex Corp by adding Medovex Corp to a well-diversified portfolio.
Medovex Corp Fundamentals Growth
Medovex OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Medovex Corp, and Medovex Corp fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Medovex OTC Stock performance.
| Return On Equity | -4.6 | |||
| Return On Asset | -3.48 | |||
| Operating Margin | (3.51) % | |||
| Current Valuation | 8.88 M | |||
| Shares Outstanding | 477.61 K | |||
| Price To Earning | (1.53) X | |||
| Price To Book | 34.90 X | |||
| Price To Sales | 3.68 X | |||
| Revenue | 1.61 M | |||
| EBITDA | (4.61 M) | |||
| Cash And Equivalents | 45.88 K | |||
| Cash Per Share | 0.16 X | |||
| Total Debt | 3.88 M | |||
| Debt To Equity | 2.61 % | |||
| Book Value Per Share | (17.98) X | |||
| Cash Flow From Operations | (4.81 M) | |||
| Earnings Per Share | (0.05) X | |||
| Total Asset | 321.4 K | |||
| Retained Earnings | (38.35 M) | |||
| Current Asset | 4.18 M | |||
| Current Liabilities | 851.22 K | |||
About Medovex Corp Performance
Assessing Medovex Corp's fundamental ratios provides investors with valuable insights into Medovex Corp's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Medovex Corp is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
H-CYTE, Inc., a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders in the United States. It has a product supply agreement with Rion, LLC to develop and distribute a biologic for chronic obstructive pulmonary disease. H CYTE operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 8 people.Things to note about Medovex Corp performance evaluation
Checking the ongoing alerts about Medovex Corp for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Medovex Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Medovex Corp is not yet fully synchronised with the market data | |
| Medovex Corp has a very high chance of going through financial distress in the upcoming years | |
| Medovex Corp currently holds 3.88 M in liabilities with Debt to Equity (D/E) ratio of 2.61, implying the company greatly relies on financing operations through barrowing. Medovex Corp has a current ratio of 0.04, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Medovex Corp until it has trouble settling it off, either with new capital or with free cash flow. So, Medovex Corp's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Medovex Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Medovex to invest in growth at high rates of return. When we think about Medovex Corp's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 1.61 M. Net Loss for the year was (4.8 M) with profit before overhead, payroll, taxes, and interest of 906.81 K. | |
| Medovex Corp currently holds about 45.88 K in cash with (4.81 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.16. | |
| Roughly 26.0% of Medovex Corp shares are held by company insiders |
- Analyzing Medovex Corp's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Medovex Corp's stock is overvalued or undervalued compared to its peers.
- Examining Medovex Corp's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Medovex Corp's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Medovex Corp's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Medovex Corp's otc stock. These opinions can provide insight into Medovex Corp's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Consideration for investing in Medovex OTC Stock
If you are still planning to invest in Medovex Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medovex Corp's history and understand the potential risks before investing.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |